Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C91711
http://purl.obolibrary.org/obo/NCIT_C91711
|
|---|---|
| Preferred Name | Trebananib |
| Definitions |
An angiopoietin (Ang) 1 and 2 neutralizing peptibody, with potential antiangiogenic activity. AMG 386 targets and binds to Ang1 and Ang2, thereby preventing the interaction of the angiopoietins with their target tie2 receptors. This may inhibit angiogenesis and may eventually lead to an inhibition of tumor cell proliferation.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | An angiopoietin (Ang) 1 and 2 neutralizing peptibody, with potential antiangiogenic activity. AMG 386 targets and binds to Ang1 and Ang2, thereby preventing the interaction of the angiopoietins with their target tie2 receptors. This may inhibit angiogenesis and may eventually lead to an inhibition of tumor cell proliferation. |
|---|---|
| prefLabel | Trebananib
|
| label | Trebananib
|
| PDQ_Closed_Trial_Search_ID | 423474
|
| code | C91711
|
| Has_Target | |
| prefixIRI | NCIT:C91711
|
| in_subset |
See more
See less
|
| Display_Name | Trebananib
|
| Preferred_Name | Trebananib
|
| FDA_UNII_Code | X8Y5U6NC7E
|
| Contributing_Source |
CTRP
FDA
|
| Maps_To | Trebananib
|
| CAS_Registry | 894356-79-7
|
| NCI_Drug_Dictionary_ID | 423474
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 423474
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C1541521
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |